Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076713 · ClinicalTrials.gov registry record
Antiphospholipid Syndrome Collaborative Registry (APSCORE)
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 860
- Enrollment target
NCT00076713: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT00076713 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 860 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00076713 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 860 participants
- Enrollment target
Study Summary
Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against them. Patients with these antibodies may experience miscarriages and blood clotting disorders, including heart attacks and strokes. APS may occur in people with systemic lupus erythematosus and other autoimmune diseases, or in otherwise healthy individuals. The Antiphospholipid Syndrome Collaborative Registry (APSCORE) is a national registry and tissue repository for patients with APS. This registry will collect clinical information and blood samples from people with APS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 860 participants |
| Start Date | 2000-04 |
| Est. Completion | 2007-04 |
What the finished NCT00076713 record still lists
NCT00076713 is an observational study that tracks outcomes without assigning an intervention. The registered 860 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00076713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00076713 about?
NCT00076713 is a clinical study titled "Antiphospholipid Syndrome Collaborative Registry (APSCORE)". Antiphospholipid Syndrome (APS) is an autoimmune disorder in which the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies against them. Patients with these antibodies may experience miscarriages and blood clotting disorders, includi...
What is the current status of trial NCT00076713?
This trial is currently completed. The enrollment target is 860 participants. The study started on 2000-04. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT00076713?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
- NCT06161025 · 860 participants · Phase 2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- NCT06541574 · 860 participants · Phase 2
Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia